RNUGF - ReNeuron Group plc

Other OTC - Other OTC Delayed Price. Currency in USD
0.000 (0.000%)
At close: 3:37PM EST
Stock chart is not supported by your current browser
Previous Close0.017
Bid0.000 x 0
Ask0.000 x 0
Day's Range0.000 - 0.000
52 Week Range
Avg. Volume4,324
Market Cap31.089M
PE Ratio (TTM)N/A
EPS (TTM)-0.008
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Accesswire7 months ago

    Edison Issues Update on ReNeuron Group (RENE)

    LONDON, UK / ACCESSWIRE / July 6, 2017 / The highlight of FY17 was positive Phase II efficacy data from ReNeuron's PISCES II clinical trial. As this and its other clinical programmes in ophthalmology and ...

  • We're sorry this is all we were able to find about this topic.